Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells
Previous studies demonstrated a direct correlation with loss of kangai-1 (KAI1), a metastasis suppressor, and poor prognosis in human prostate and other cancers. In this study, we have characterized the age-dependent downregulation of KAI1 in the TRAMP model which was reversed when mice were fed a g...
Gespeichert in:
Veröffentlicht in: | Biochemical and biophysical research communications 2007-09, Vol.361 (1), p.169-175 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 175 |
---|---|
container_issue | 1 |
container_start_page | 169 |
container_title | Biochemical and biophysical research communications |
container_volume | 361 |
creator | El Touny, Lara H. Banerjee, Partha P. |
description | Previous studies demonstrated a direct correlation with loss of kangai-1 (KAI1), a metastasis suppressor, and poor prognosis in human prostate and other cancers. In this study, we have characterized the age-dependent downregulation of KAI1 in the TRAMP model which was reversed when mice were fed a genistein-enriched diet. We demonstrated here that doses of genistein (5 and 10
μM)—achievable by supplement intake—significantly induced the expression of KAI1, both at the mRNA and protein levels (up to 2.5-fold), and decreased the invasiveness of TRAMP-C2 cells >2.0-fold. We have pinpointed KAI1 as the invasion suppressor, since its knockdown by siRNA restored the invasive potential of genistein-treated TRAMP-C2 cells to control levels. This work provides the first evidence that genistein treatment may counteract KAI1 downregulation, which is observed in many cancer types and therefore, could be used in anti-metastatic therapies. |
doi_str_mv | 10.1016/j.bbrc.2007.07.010 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2075085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X07014520</els_id><sourcerecordid>68114538</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-96e9ff1c3916e0fe7ddd47318e78d663c3e9c461fa6f0eb262fa657c96b2a07d3</originalsourceid><addsrcrecordid>eNp9UV1rFDEUDWKx2-of8EHy5NusN_ORmYAIpdQqVFpKBd9CJrnTzbqbWXMzK_77ZtjFjxfhQEJyzsnNOYy9FrAUIOS79bLvo12WAO1yhoBnbCFAQVEKqJ-zBQDIolTi2yk7I1oDCFFL9YKdilY2Xd2qBaNrDJ4S-sB9cJNF4mmFfIvJUIYnTtNuF5FojPy7CY_GF4L_XHm7yiTnTcoKn4ibkHzhwz5r9shxGNDm02z7cH_x5Y5bEyxGbnGzoZfsZDAbwlfH9Zx9_Xj1cPmpuLm9_nx5cVPYuqlSoSSqYRC2UkIiDNg65-q2Eh22nZOyshUqW0sxGDkA9qUs865prZJ9aaB11Tn7cPDdTX2e1WJI0Wz0Lvqtib_0aLz-9yb4lX4c97qEtoGuyQZvjwZx_DEhJb31NH_BBBwn0rLLgTZVl4nlgWjjSBRx-P2IAD13pdd67krPXekZArLozd_j_ZEcy8mE9wcC5pD2HqMm6zHn6HzM6Wo3-v_5PwH9gqjL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68114538</pqid></control><display><type>article</type><title>Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>El Touny, Lara H. ; Banerjee, Partha P.</creator><creatorcontrib>El Touny, Lara H. ; Banerjee, Partha P.</creatorcontrib><description>Previous studies demonstrated a direct correlation with loss of kangai-1 (KAI1), a metastasis suppressor, and poor prognosis in human prostate and other cancers. In this study, we have characterized the age-dependent downregulation of KAI1 in the TRAMP model which was reversed when mice were fed a genistein-enriched diet. We demonstrated here that doses of genistein (5 and 10
μM)—achievable by supplement intake—significantly induced the expression of KAI1, both at the mRNA and protein levels (up to 2.5-fold), and decreased the invasiveness of TRAMP-C2 cells >2.0-fold. We have pinpointed KAI1 as the invasion suppressor, since its knockdown by siRNA restored the invasive potential of genistein-treated TRAMP-C2 cells to control levels. This work provides the first evidence that genistein treatment may counteract KAI1 downregulation, which is observed in many cancer types and therefore, could be used in anti-metastatic therapies.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2007.07.010</identifier><identifier>PMID: 17658479</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age Factors ; Animals ; Anticarcinogenic Agents - pharmacology ; CD82 ; Cell Line, Tumor ; Disease Progression ; Genistein ; Genistein - pharmacology ; KAI1/kangai ; Kangai-1 Protein - antagonists & inhibitors ; Kangai-1 Protein - biosynthesis ; Kangai-1 Protein - genetics ; Male ; Metastasis ; Mice ; Neoplasm Invasiveness ; Phytoestrogen ; Prostate cancer ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; RNA Interference ; TRAMP</subject><ispartof>Biochemical and biophysical research communications, 2007-09, Vol.361 (1), p.169-175</ispartof><rights>2007 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-96e9ff1c3916e0fe7ddd47318e78d663c3e9c461fa6f0eb262fa657c96b2a07d3</citedby><cites>FETCH-LOGICAL-c453t-96e9ff1c3916e0fe7ddd47318e78d663c3e9c461fa6f0eb262fa657c96b2a07d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbrc.2007.07.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,315,781,785,886,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17658479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El Touny, Lara H.</creatorcontrib><creatorcontrib>Banerjee, Partha P.</creatorcontrib><title>Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Previous studies demonstrated a direct correlation with loss of kangai-1 (KAI1), a metastasis suppressor, and poor prognosis in human prostate and other cancers. In this study, we have characterized the age-dependent downregulation of KAI1 in the TRAMP model which was reversed when mice were fed a genistein-enriched diet. We demonstrated here that doses of genistein (5 and 10
μM)—achievable by supplement intake—significantly induced the expression of KAI1, both at the mRNA and protein levels (up to 2.5-fold), and decreased the invasiveness of TRAMP-C2 cells >2.0-fold. We have pinpointed KAI1 as the invasion suppressor, since its knockdown by siRNA restored the invasive potential of genistein-treated TRAMP-C2 cells to control levels. This work provides the first evidence that genistein treatment may counteract KAI1 downregulation, which is observed in many cancer types and therefore, could be used in anti-metastatic therapies.</description><subject>Age Factors</subject><subject>Animals</subject><subject>Anticarcinogenic Agents - pharmacology</subject><subject>CD82</subject><subject>Cell Line, Tumor</subject><subject>Disease Progression</subject><subject>Genistein</subject><subject>Genistein - pharmacology</subject><subject>KAI1/kangai</subject><subject>Kangai-1 Protein - antagonists & inhibitors</subject><subject>Kangai-1 Protein - biosynthesis</subject><subject>Kangai-1 Protein - genetics</subject><subject>Male</subject><subject>Metastasis</subject><subject>Mice</subject><subject>Neoplasm Invasiveness</subject><subject>Phytoestrogen</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>RNA Interference</subject><subject>TRAMP</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UV1rFDEUDWKx2-of8EHy5NusN_ORmYAIpdQqVFpKBd9CJrnTzbqbWXMzK_77ZtjFjxfhQEJyzsnNOYy9FrAUIOS79bLvo12WAO1yhoBnbCFAQVEKqJ-zBQDIolTi2yk7I1oDCFFL9YKdilY2Xd2qBaNrDJ4S-sB9cJNF4mmFfIvJUIYnTtNuF5FojPy7CY_GF4L_XHm7yiTnTcoKn4ibkHzhwz5r9shxGNDm02z7cH_x5Y5bEyxGbnGzoZfsZDAbwlfH9Zx9_Xj1cPmpuLm9_nx5cVPYuqlSoSSqYRC2UkIiDNg65-q2Eh22nZOyshUqW0sxGDkA9qUs865prZJ9aaB11Tn7cPDdTX2e1WJI0Wz0Lvqtib_0aLz-9yb4lX4c97qEtoGuyQZvjwZx_DEhJb31NH_BBBwn0rLLgTZVl4nlgWjjSBRx-P2IAD13pdd67krPXekZArLozd_j_ZEcy8mE9wcC5pD2HqMm6zHn6HzM6Wo3-v_5PwH9gqjL</recordid><startdate>20070914</startdate><enddate>20070914</enddate><creator>El Touny, Lara H.</creator><creator>Banerjee, Partha P.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20070914</creationdate><title>Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells</title><author>El Touny, Lara H. ; Banerjee, Partha P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-96e9ff1c3916e0fe7ddd47318e78d663c3e9c461fa6f0eb262fa657c96b2a07d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Age Factors</topic><topic>Animals</topic><topic>Anticarcinogenic Agents - pharmacology</topic><topic>CD82</topic><topic>Cell Line, Tumor</topic><topic>Disease Progression</topic><topic>Genistein</topic><topic>Genistein - pharmacology</topic><topic>KAI1/kangai</topic><topic>Kangai-1 Protein - antagonists & inhibitors</topic><topic>Kangai-1 Protein - biosynthesis</topic><topic>Kangai-1 Protein - genetics</topic><topic>Male</topic><topic>Metastasis</topic><topic>Mice</topic><topic>Neoplasm Invasiveness</topic><topic>Phytoestrogen</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>RNA Interference</topic><topic>TRAMP</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El Touny, Lara H.</creatorcontrib><creatorcontrib>Banerjee, Partha P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El Touny, Lara H.</au><au>Banerjee, Partha P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2007-09-14</date><risdate>2007</risdate><volume>361</volume><issue>1</issue><spage>169</spage><epage>175</epage><pages>169-175</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Previous studies demonstrated a direct correlation with loss of kangai-1 (KAI1), a metastasis suppressor, and poor prognosis in human prostate and other cancers. In this study, we have characterized the age-dependent downregulation of KAI1 in the TRAMP model which was reversed when mice were fed a genistein-enriched diet. We demonstrated here that doses of genistein (5 and 10
μM)—achievable by supplement intake—significantly induced the expression of KAI1, both at the mRNA and protein levels (up to 2.5-fold), and decreased the invasiveness of TRAMP-C2 cells >2.0-fold. We have pinpointed KAI1 as the invasion suppressor, since its knockdown by siRNA restored the invasive potential of genistein-treated TRAMP-C2 cells to control levels. This work provides the first evidence that genistein treatment may counteract KAI1 downregulation, which is observed in many cancer types and therefore, could be used in anti-metastatic therapies.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>17658479</pmid><doi>10.1016/j.bbrc.2007.07.010</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-291X |
ispartof | Biochemical and biophysical research communications, 2007-09, Vol.361 (1), p.169-175 |
issn | 0006-291X 1090-2104 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2075085 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Age Factors Animals Anticarcinogenic Agents - pharmacology CD82 Cell Line, Tumor Disease Progression Genistein Genistein - pharmacology KAI1/kangai Kangai-1 Protein - antagonists & inhibitors Kangai-1 Protein - biosynthesis Kangai-1 Protein - genetics Male Metastasis Mice Neoplasm Invasiveness Phytoestrogen Prostate cancer Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology RNA Interference TRAMP |
title | Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T08%3A32%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genistein%20induces%20the%20metastasis%20suppressor%20kangai-1%20which%20mediates%20its%20anti-invasive%20effects%20in%20TRAMP%20cancer%20cells&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=El%20Touny,%20Lara%20H.&rft.date=2007-09-14&rft.volume=361&rft.issue=1&rft.spage=169&rft.epage=175&rft.pages=169-175&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2007.07.010&rft_dat=%3Cproquest_pubme%3E68114538%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68114538&rft_id=info:pmid/17658479&rft_els_id=S0006291X07014520&rfr_iscdi=true |